The amount of milestone consideration on product sales accrued and payable as certain milestones were achieved.

No definition available.

Name:	imnm_CollaborativeAndLicenseAgreementsMilestonesPaymentsOnProductSalesAccruedAndPayableAsMilestonesAchieved
Namespace Prefix:	imnm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of in process research and development expense incurred during the year.

+ References

No definition available.

+ Details

Name:	imnm_InProcessResearchAndDevelopmentExpense
Namespace Prefix:	imnm_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the upfront payment in cash under license agreement.

+ References

No definition available.

+ Details

Name:	imnm_LicenseAgreementUpfrontPaymentInCash
Namespace Prefix:	imnm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=imnm_OtherAssetPurchaseAndLicenseAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Strategic transactions and agreements - Other asset acquisitions and license agreements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
In-process research and development	$ 0	$ 6,706	$ 0	$ 124,972
Other asset acquisitions and license agreements
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Accrued expenses and other current liabilities					$ 1,200
Upfront consideration paid in cash		$ 4,000		$ 10,300